I

Illumina
D

ILMN

137.020
USD
5.33
(4.05%)
Market Closed
Volume
83,067
EPS
3
Div Yield
-
P/E
-7
Market Cap
21,827,286,000
OverviewSignalsIdeasNews
Related Instruments
    ABT
    ABT
    0.850
    (0.74%)
    117.25 USD
    A
    ALGN
    2.230
    (1.01%)
    223.930 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    289.88 USD
    BDX
    BDX
    -2.040
    (-0.90%)
    225.190 USD
    B
    BMRN
    -2.200
    (-3.35%)
    63.440 USD
    DHR
    DHR
    -8.985
    (-3.75%)
    235.05 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    L
    LH
    -3.029
    (-1.27%)
    235.180 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    516.18 USD
    More
News

Title: Illumina

Sector: Healthcare
Industry: Diagnostics & Research
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.